Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled, Phase I Studies in Healthy Individuals and Patients With Mild SARS-CoV-2 Infection

Autor: Kim, Jin Yong, Jang, Young Rock, Hong, Jang Hee, Jung, Jin Gyu, Park, Jae-Hyeong, Streinu-Cercel, Adrian, Streinu-Cercel, Anca, Săndulescu, Oana, Lee, Sang Joon, Kim, Sung Hyun, Jung, Na Hyun, Lee, Seul Gi, Park, Jeong Eun, Kim, Min Kyung, Jeon, Da Bee, Lee, Yeo Jin, Kim, Bum Soo, Lee, Yeon Mi, Kim, Yeon-Sook
Zdroj: In Clinical Therapeutics October 2021 43(10):1706-1727
Databáze: ScienceDirect
Externí odkaz: